We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Crowdfunding Opportunities in Medical


Aerobit Health Medical EIS SEIS
Aerobit is a smart inhaler, a tool for tracking medication use that records each time inhalers are taken and comes in a variety of cool toy designs. Built in sensors can even tell if the inhaler has been shaken correctly. 
investment: £116,960 target: £250,000 pre-money valuation: £1,299,907
status: Expired
More Information
47%
United Medicine Medical EIS
United Medicine have created a platform where experience, knowledge and opinion of their medical users is used to provide a global consensus and allows the good evidence to be separated from the bad.   
investment: £152,000 target: £300,000 pre-money valuation: £600,090
status: Expired
More Information
51%
NowMe Infinity Medical EIS
An end-to-end digital platform providing aesthetic medical treatment in a market valued at almost £76bn. NowMe work closely with customers throughout the process by discussing the treatment they desire, selecting an appropriate medical practitioner from a UK Clinic and offering available finance solutions. The company is raising funds to refine their product and secure IP, as well as cover working capital requirements. The firm plan to launch in 2018 and by 2025 achieve international leadership.
investment: £172,790 target: £300,000 pre-money valuation: £1,500,000
status: Expired
More Information
58%
PlaqueTec Medical EIS
Cardiovascular Disease is the leading cause of death in the UK, PlaqueTec have developed a Liquid Biopsy System, which allows cardiologists to gain further information from a patient's coronary artery and provide more effective treatment to those affected by the disease.
investment: £1,493,593 target: £2,100,058 pre-money valuation: £12,003,757
status: Expired
More Information
71%
Trecento Diagnostics Medical EIS SEIS
Trecento Diagnostics, with the help of a molecular testing system complete, they are now ready to launch a patent-pending collection device named HygieCatch®. It is a non-invasive, needle-free examination, in the vet practice providing DNA extraction from urine onsite with a report within 40 minutes of extraction of the sample. The company has identified partners in the UAE and US and is also in early-stage discussions with UK vet practices.  Furthermore, for the purpose of commercialisation of HygieCatch & the technology used, alongside addition of new tests including Lyme disease the company is planning to raise its capital.  
investment: £167,910 target: £250,000 pre-money valuation: £2,375,000
status: Expired
More Information
67%
Combat Medical Medical EIS
Combat Medical have created an innovative method to treat bladder cancer by using heated chemotherapy. By heating the treatment the membrane is more permeable and is able to penetrate further. 
investment: £1,725,220 target: £700,000 pre-money valuation: £20,243,298
status: Funded
More Information
246%
Metrion Biosciences Medical EIS
Metrion Biosciences is a pharmaceutical research organisation that provide a high quality drug discovery services for ion channel targets to clients on a fee-for-service or collaboration basis.
investment: £465,150 target: £300,000 pre-money valuation: £1,501,802
status: Expired
More Information
155%
ENXRAY Medical
EnXray are developing Low Energy X-ray (LEXR) technologies to sterilise equipment in commercial or research settings where low volume/high value therapeutic products, such as cancer vaccines and stem cell implants are being developed. Their aim is to reduce the need for third party providers and have the sterilisation process done on-site and on-demand with simple and safe equipment to reduce cost and save time for medical research organisations.
investment: £376,230 target: £400,000 pre-money valuation: £4,924,046
status: Expired
More Information
94%
Qured Medical EIS
Providing convenient and affordable healthcare to patients either at home or their workplace. Practitioners can visit patients and offer a range of medical treatments including vaccinations, testing, physiotherapy and primary care. Qured have been highly successful in London and are growing at an alarming rate, ready to help the whole of the UK.
investment: £751,850 target: £500,000 pre-money valuation: £7,000,000
status: Expired
More Information
150%
Fertility Focus Medical
OvuSense has been designed for women that struggle to conceive, actively predicting fertility patterns.  The OvuSense system has two parts a smartphone app and a medical grade vaginal sensor. OvuSense works for all women. The product gives a 24 hour prediction within your cycle.
investment: £100,000 target: £250,000
status: Expired
More Information
40%
Molecular Warehouse Medical EIS
Molecular Warehouse are trying to create a world where most diseases are prevented by giving people the chance to monitor and manage their helath where ever and whenever. Molecular Warehouse have developed a platform that allows anyone to test themselves at any time.
investment: £420,110 target: £300,000 pre-money valuation: £3,949,292
status: Stretch
More Information
140%
Stablepharma Medical EIS
Stablepharma invents a disruptive solution that can eliminate waste and supply life-saving vaccines without refrigeration. It is a patented invention that allows vaccines to be stored for years and transported without refrigeration whilst adhering with the protocols established by the WHO. Its current project plan comprises the Tetanus vaccine processed by Clinical Trials in Humans. The success of this project will significantly enhance the value of the invention and allow it to set up a pilot scale production in the $36 bn human vaccine market.
investment: £1,350,650 target: £750,000 pre-money valuation: £10,000,000
status: Expired
More Information
180%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph